A detailed history of Klcm Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Klcm Advisors, Inc. holds 131,710 shares of PFE stock, worth $3.41 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
131,710
Previous 128,672 2.36%
Holding current value
$3.41 Million
Previous $3.6 Million 5.86%
% of portfolio
0.46%
Previous 0.45%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $84,152 - $95,362
3,038 Added 2.36%
131,710 $3.81 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $1.3 Million - $1.52 Million
-51,267 Reduced 28.49%
128,672 $3.6 Million
Q1 2024

May 16, 2024

BUY
$25.89 - $29.73 $159,119 - $182,720
6,146 Added 3.54%
179,939 $4.99 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $1.95 Million - $2.53 Million
74,487 Added 75.01%
173,793 $5 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $175,307 - $204,917
5,463 Added 5.82%
99,306 $3.29 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $121,796 - $140,915
-3,372 Reduced 3.47%
93,843 $3.44 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $2.51 Million - $3.27 Million
63,702 Added 190.08%
97,215 $3.97 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $162,365 - $211,950
3,889 Added 13.13%
33,513 $1.72 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $119,246 - $145,569
2,725 Added 10.13%
29,624 $1.3 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $78,821 - $93,457
-1,694 Reduced 5.92%
26,899 $1.41 Million
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $7.33 Million - $9.08 Million
-160,172 Reduced 84.85%
28,593 $1.48 Million
Q4 2021

Jan 31, 2022

SELL
$41.32 - $61.25 $362,872 - $537,897
-8,782 Reduced 4.45%
188,765 $11.1 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $8.85 Million - $11.4 Million
-225,429 Reduced 53.3%
197,547 $8.5 Million
Q2 2021

Aug 03, 2021

SELL
$35.91 - $40.68 $1.58 Million - $1.78 Million
-43,878 Reduced 9.4%
422,976 $16.6 Million
Q1 2021

Apr 21, 2021

BUY
$33.49 - $37.77 $1.47 Million - $1.66 Million
43,871 Added 10.37%
466,854 $16.9 Million
Q4 2020

Jan 26, 2021

BUY
$33.47 - $42.56 $384,637 - $489,099
11,492 Added 2.79%
422,983 $15.6 Million
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $779,176 - $914,152
-24,541 Reduced 5.63%
411,491 $15.1 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $977,273 - $1.19 Million
-32,446 Reduced 6.93%
436,032 $14.3 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $173,262 - $247,554
6,410 Added 1.39%
468,478 $15.3 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $468,780 - $532,006
14,240 Added 3.18%
462,068 $18.1 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $974,505 - $1.26 Million
29,994 Added 7.18%
447,828 $16.1 Million
Q3 2019

Nov 04, 2019

BUY
$32.49 - $42.13 $275,482 - $357,220
8,479 Added 2.07%
417,834 $15 Million
Q3 2019

Nov 04, 2019

BUY
$32.49 - $42.13 $1.29 Million - $1.68 Million
39,780 Added 10.76%
409,355 $14.7 Million
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $122,810 - $137,887
3,321 Added 0.91%
369,575 $16 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $319,050 - $350,529
8,508 Added 2.38%
366,254 $15.6 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $227,588 - $259,475
-5,916 Reduced 1.63%
357,746 $15.6 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $756,995 - $918,189
-21,961 Reduced 5.69%
363,662 $16 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $161,371 - $172,037
4,893 Added 1.29%
385,623 $14 Million
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $490,105 - $568,590
-15,359 Reduced 3.88%
380,730 $13.5 Million
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $71,575 - $75,944
2,152 Added 0.55%
396,089 $14.3 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $362,359 - $399,179
-11,689 Reduced 2.88%
393,937 $14.1 Million
Q2 2017

Aug 15, 2017

BUY
N/A
405,626
405,626 $13.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Klcm Advisors, Inc. Portfolio

Follow Klcm Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.